Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Needham

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Professional Nurse (London, England)|August 1, 1997
GlaucomaY Needham
Insight (American Society of Ophthalmic Registered Nurses)|March 23, 2002
Developing the role of the ophthalmic nurse in EnglandY Needham
NT Learning Curve|May 5, 2000
Information technology. Open learning with MerlinC Jackson, Y Needham, L Smith
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 10, 2002
Using the Web to develop an EN conversion courseD Bahn, Y Needham, D Marsh
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 10, 2025
A standard operating procedure for reducing risk from medications prohibited during clinical trials in cystic fibrosisM Le Sayec, G Davies, M D Waller, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Professional Nurse (London, England)|August 1, 1997
GlaucomaY Needham
Insight (American Society of Ophthalmic Registered Nurses)|March 23, 2002
Developing the role of the ophthalmic nurse in EnglandY Needham
NT Learning Curve|May 5, 2000
Information technology. Open learning with MerlinC Jackson, Y Needham, L Smith
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|September 10, 2002
Using the Web to develop an EN conversion courseD Bahn, Y Needham, D Marsh
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 10, 2025
A standard operating procedure for reducing risk from medications prohibited during clinical trials in cystic fibrosisM Le Sayec, G Davies, M D Waller, et al.
Pageof 1